IBDEI0YQ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17143,1,4,0)
 ;;=4^338.22
 ;;^UTILITY(U,$J,358.3,17143,1,5,0)
 ;;=5^Chronic Post-Thoracotomy Pain
 ;;^UTILITY(U,$J,358.3,17143,2)
 ;;=^334075
 ;;^UTILITY(U,$J,358.3,17144,0)
 ;;=338.28^^92^947^28
 ;;^UTILITY(U,$J,358.3,17144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17144,1,4,0)
 ;;=4^338.28
 ;;^UTILITY(U,$J,358.3,17144,1,5,0)
 ;;=5^Other Chronic Postop Pain
 ;;^UTILITY(U,$J,358.3,17144,2)
 ;;=^334076
 ;;^UTILITY(U,$J,358.3,17145,0)
 ;;=338.29^^92^947^27
 ;;^UTILITY(U,$J,358.3,17145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17145,1,4,0)
 ;;=4^338.29
 ;;^UTILITY(U,$J,358.3,17145,1,5,0)
 ;;=5^Other Chronic Pain
 ;;^UTILITY(U,$J,358.3,17145,2)
 ;;=^334077
 ;;^UTILITY(U,$J,358.3,17146,0)
 ;;=338.3^^92^947^8
 ;;^UTILITY(U,$J,358.3,17146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17146,1,4,0)
 ;;=4^338.3
 ;;^UTILITY(U,$J,358.3,17146,1,5,0)
 ;;=5^Cancer Associated Pain
 ;;^UTILITY(U,$J,358.3,17146,2)
 ;;=^334078
 ;;^UTILITY(U,$J,358.3,17147,0)
 ;;=338.4^^92^947^11
 ;;^UTILITY(U,$J,358.3,17147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17147,1,4,0)
 ;;=4^338.4
 ;;^UTILITY(U,$J,358.3,17147,1,5,0)
 ;;=5^Chronic Pain Syndrome
 ;;^UTILITY(U,$J,358.3,17147,2)
 ;;=^334079
 ;;^UTILITY(U,$J,358.3,17148,0)
 ;;=780.96^^92^947^17
 ;;^UTILITY(U,$J,358.3,17148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17148,1,4,0)
 ;;=4^780.96
 ;;^UTILITY(U,$J,358.3,17148,1,5,0)
 ;;=5^Generalized Pain
 ;;^UTILITY(U,$J,358.3,17148,2)
 ;;=^334163
 ;;^UTILITY(U,$J,358.3,17149,0)
 ;;=607.9^^92^947^30
 ;;^UTILITY(U,$J,358.3,17149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17149,1,4,0)
 ;;=4^607.9
 ;;^UTILITY(U,$J,358.3,17149,1,5,0)
 ;;=5^Penile Pain
 ;;^UTILITY(U,$J,358.3,17149,2)
 ;;=^270442
 ;;^UTILITY(U,$J,358.3,17150,0)
 ;;=608.9^^92^947^32
 ;;^UTILITY(U,$J,358.3,17150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17150,1,4,0)
 ;;=4^608.9
 ;;^UTILITY(U,$J,358.3,17150,1,5,0)
 ;;=5^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,17150,2)
 ;;=^123856
 ;;^UTILITY(U,$J,358.3,17151,0)
 ;;=V68.1^^92^948^4
 ;;^UTILITY(U,$J,358.3,17151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17151,1,4,0)
 ;;=4^V68.1
 ;;^UTILITY(U,$J,358.3,17151,1,5,0)
 ;;=5^Rx Refill (Also mark Condition)
 ;;^UTILITY(U,$J,358.3,17151,2)
 ;;=RX Refill (also mark Condition)^295585
 ;;^UTILITY(U,$J,358.3,17152,0)
 ;;=V68.81^^92^948^6
 ;;^UTILITY(U,$J,358.3,17152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17152,1,4,0)
 ;;=4^V68.81
 ;;^UTILITY(U,$J,358.3,17152,1,5,0)
 ;;=5^Transfer of Care (Also Mark Dx)
 ;;^UTILITY(U,$J,358.3,17152,2)
 ;;=Transfer of Care ^295587
 ;;^UTILITY(U,$J,358.3,17153,0)
 ;;=V58.83^^92^948^5
 ;;^UTILITY(U,$J,358.3,17153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17153,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,17153,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,17153,2)
 ;;=Encounter for Therapeutic Drug Monitoring^322076
 ;;^UTILITY(U,$J,358.3,17154,0)
 ;;=V65.19^^92^948^3
 ;;^UTILITY(U,$J,358.3,17154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17154,1,4,0)
 ;;=4^V65.19
 ;;^UTILITY(U,$J,358.3,17154,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,17154,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,17155,0)
 ;;=V60.89^^92^948^1
 ;;^UTILITY(U,$J,358.3,17155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17155,1,4,0)
 ;;=4^V60.89
 ;;^UTILITY(U,$J,358.3,17155,1,5,0)
 ;;=5^Housing/Economic Circumstances
 ;;^UTILITY(U,$J,358.3,17155,2)
 ;;=^295545
 ;;^UTILITY(U,$J,358.3,17156,0)
 ;;=V68.09^^92^948^2
 ;;^UTILITY(U,$J,358.3,17156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17156,1,4,0)
 ;;=4^V68.09
